Home > Dáil Éireann debate. Question 509 - Medicinal products [Pregabalin] [40993/23].

[Oireachtas] Dáil Éireann debate. Question 509 - Medicinal products [Pregabalin] [40993/23]. (26 Sep 2023)

External website: https://www.oireachtas.ie/en/debates/question/2023...

509. Deputy Aodhán Ó Ríordáin asked the Minister for Health what measures he will take to increase the awareness of the danger for abuse and misuse of the drug pregabalin among the medical community; and if he will make a statement on the matter. [40993/23]

Stephen Donnelly, Minister for Health: In 2019, the Medical Council established an ‘Overprescribing Working Group’ to consider issues with overprescribing of controlled drugs within the healthcare system. The aim of the group was to create a forum for stakeholders to share knowledge, experience and ideas on how to address overprescribing of benzodiazepines, Z drugs and Pregabalin, and also to identify strategies to reduce the over prescribing of these drugs in the interest of patient and practitioner safety, and to support prescribers in adherence with guidelines.

The Working Group includes representatives from my Department, the HSE, the Pharmaceutical Society of Ireland, the Irish College of General Practitioners, the Nursing and Midwifery Board of Ireland, the Health Products Regulatory Agency and the Irish College of Psychiatry.

The group is currently working on a report which is examining the impact of the overprescribing of benzodiazepines, Z drugs and pregabalin in Ireland and it is estimated that this report will be finalised next year.

Following examination of the recommendations of this report, I will consider what measures need to be taken to support medical practitioners in the area of safe prescribing and to address any patient safety concerns arising.

Repository Staff Only: item control page